What is IVD in Vitro Diagnostic Reagent？

IVD in vitro diagnostic reagent registration refers to the process of submitting IVD in vitro diagnostic reagent products to relevant regulatory agencies (such as FDA, CE, CFDA, etc.), and obtaining a license certificate after review, evaluation, certification, allowing sale and use on the market. This process requires compliance with relevant laws, regulations and specifications, including ISO 13485 quality management system, ISO 14971 risk management system, GMP (Good Manufacturing Practice), etc.

IVD in vitro diagnostic reagent registration process includes application, review, evaluation, license issuance and other links. The applicant is required to provide product-related information and supporting documents, including product technical specifications, safety assessment, clinical trial data, quality assurance plan, etc. These documents will be reviewed and evaluated by the regulatory body, and the evaluation results may include approval, need for supplementary materials, rejection, etc. If approved, the applicant can obtain a license, obtaining the right to sell and use.

Its classification may vary by country, region, industry, etc.  


Detailed steps and procedures for clinical trial registration of diagnostic reagents

1、Determine the test protocol and study design
In the design of the experimental scheme and the design of the study, it is necessary to consider the purpose of the experiment, the study object, the sample size, the research method, the data analysis and other aspects, and ensure that the experimental scheme meets the ethical and legal requirements.

2、Choose the right registration platform
A number of in vitro diagnostic reagent Clinical trial registration platforms have been established internationally, such as ClinicalTrials.gov, EU ClinicalTrials Register, etc. Choosing the right platform requires consideration of issues such as platform reliability, registration process and cost.

3、Register the trial and submit relevant information
When registering a trial, it is necessary to submit information such as the test protocol, study design, study purpose, and test results, and ensure the accuracy and completeness of the information. After registration, the trial protocol will be made public and can be searched and viewed on the registration platform.

4、Get Ethics Committee approval
Ethics Committee approval is required before clinical trials of in vitro diagnostic reagents can be conducted. Ethics committees need to review trial protocols and study designs to ensure that trials meet ethical and legal requirements.

5、Start the test
During the course of the test, it is necessary to follow the test protocol and study design, collect, analyze and report the test data.

6、Update registration information
During the course of the trial, if the trial protocol or study design changes, it is necessary to update the registration information in a timely manner and submit the updated information to the registration authority.

7、Complete the test and submit the evaluation information
After the completion of the test, the test results need to be evaluated and analyzed, and the results are submitted to the relevant authorities for review and approval. These can be regulatory agencies, academic institutions, medical institutions, etc., whose main task is to ensure the scientific and reliable results of trials to protect public health and safety.


IVD in vitro diagnostic reagent registration data：

The information required for international IVD in vitro diagnostic reagent registration may vary by country and region, but generally includes the following：

Product registration application form：
The application form needs to fill in the basic information of the product, including the product name, model, use, applicable group, etc.

Product specification：
Product specifications need to describe the performance of the product in detail, use methods, precautions, etc.

Product labels and packaging：
Product labels and packaging must comply with local standards, including text, graphics, bar codes, etc.

Product test report：
It is required to provide product test reports, including product performance indicators, safety, effectiveness, etc.

Manufacturer's quality management system certification：
The manufacturer needs to provide proof of the quality management system, such as ISO 13485 certification.

Business license and production license of the manufacturer：
Need to provide the manufacturer's business license and production license and other relevant supporting documents.

Product sales license：
Some countries and regions require that products need to obtain local sales licenses before sales, and the corresponding supporting documents need to be provided.

Other relevant supporting documents：
Depending on local regulations, other relevant supporting documents may be required, such as CE registration certificate, FDA registration certificate, etc.

In short, to do the international in vitro diagnostic reagent clinical trial registration needs to pay attention to the selection of registration platform, the accuracy and integrity of registration information, and timely update of registration information and submission of evaluation information. At the same time, care needs to be taken to comply with ethical and legal requirements to ensure that the trial is scientific and credible.